secwatch.observer — SEC 8-K summary
======================================

Issuer:     Black Bird Biotech, Inc. (—)
CIK:        0001409999
Form:       8-K
Filed at:   2024-03-05T23:59:59+00:00
Accession:  0001477932-24-001034
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Black Bird Biotech control changes to Nelson W. Grist; he becomes CEO
---------------------------------------------------------------------

- Grist acquires ~55.95% of Series A Preferred from four directors for $75K (cash + notes).
- Upon closing, Grist will hold ~46.83% voting control via ownership and voting agreement.
- All current directors expected to resign; Grist to be sole Director.
- Grist appointed CEO effective March 4, 2024; prior CEO of For the Earth Corp. and Perk International.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1409999/000147793224001034/0001477932-24-001034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1409999/000147793224001034/bbbt_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-24-001034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer